Multisystemic Therapy-Emerging Adults Trial

NCT02922335 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 193

Last updated 2023-05-22

No results posted yet for this study

Summary

This study's purpose is to test the effectiveness of a promising intervention for emerging adults (EAs) with mental illness (MI) and serious antisocial behavior in achieving the ultimate outcome of reduced antisocial behavior, and proximal intermediate outcomes. Multisystemic Therapy-Emerging Adults (MST-EA) is an adaptation of MST, a well-established, effective intervention for antisocial behavior in adolescents.

Conditions

  • Antisocial Behavior

Interventions

BEHAVIORAL

Multisystemic Therapy for Emerging Adults

MST-EA is a home-based therapy in which therapists work closely with each young adult. Therapists often also work with the young person's family, as appropriate. MST-EA is designed to help young people work on their own behavior. This treatment also involves the use of coaches who help young people develop skills for young adulthood.

BEHAVIORAL

Enhanced Treatment as Usual

Standard services that a young person would receive if they have been in trouble with the law and also have a mental illness.

Sponsors & Collaborators

  • National Institute of Mental Health (NIMH)

    collaborator NIH
  • Oregon Social Learning Center

    collaborator OTHER
  • Connecticut Department of Children and Families

    collaborator UNKNOWN
  • North American Family Institute

    collaborator UNKNOWN
  • Court Support Services Division

    collaborator UNKNOWN
  • Youth Villages

    collaborator OTHER
  • University of Massachusetts, Worcester

    lead OTHER

Principal Investigators

  • Maryann Davis, PhD · University of Massachusetts, Worcester

  • Ashli Sheidow, PhD · Oregon Social Learning Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
16 Years
Max Age
26 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-09-01
Primary Completion
2022-09-01
Completion
2023-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02922335 on ClinicalTrials.gov